INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
No time served or fines paid in work zone deaths
The driver in a deadly crash that killed two Rieth-Riley construction workers in May 2014 has not served any jail time or paid any fine.
Anderson pool closed due to staffing shortage
An Anderson city pool was unable to open over the Fourth of July weekend due to a staffing shortage.
No injuries in acid spill at Coca Cola plant
Authorities are investigating how a form of acid spilled outside the Coca Cola facility in Speedway.
2 dead, dozens injured in fireworks incidents
Two Indiana residents died over the weekend in fireworks-related incidents.
Scammer pretending to be with paving company
The Better Business Bureau is warning Hoosiers to be on the lookout for a man pretending to be with a paving company and threatening people…